发明名称 |
Cellular vaccine and method of inducing an immune response in a subject |
摘要 |
The present invention relates to methods of inducing or enhancing an immune response against an immunogen in a subject. The invention further includes isolated nucleic acid vaccines, cellular vaccines, fusion proteins, expression vectors, vaccines, and immunogenic compositions for use therein. |
申请公布号 |
US9585952(B2) |
申请公布日期 |
2017.03.07 |
申请号 |
US201314401182 |
申请日期 |
2013.05.16 |
申请人 |
ADELAIDE RESEARCH & INNOVATION PTY LTD |
发明人 |
Gowans Eric James |
分类号 |
A61K47/48;A61K39/29;A61K31/711;A61K39/12;A61K35/12;A61K39/21;C12N7/00;A61K39/00 |
主分类号 |
A61K47/48 |
代理机构 |
MH2 Technology Law Group, LLP |
代理人 |
MH2 Technology Law Group, LLP |
主权项 |
1. An immunogenic composition comprising a DNA construct comprising:
a. a first nucleic acid sequence encoding a polypeptide having cell death inducing activity, wherein the polypeptide is perforin, and wherein the first nucleic acid sequence is operatively linked to a first promoter; and b. a second nucleic acid sequence encoding an immunogenic polypeptide, wherein the second nucleic acid sequence is operatively linked to a second promoter, and wherein the second promoter has a greater relative efficacy than the first promoter. |
地址 |
Adelaide AU |